MELISSA HUBBS: Open Payments
NPI 1386884963 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,597 in 49 payments from 17 companies in 2025. Trend: 2023 $1,762 · 2024 $1,888 · 2025 $1,597
Food & beverage: $1,597
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 4 | $261 |
| Insulet Corporation | 9 | $205 |
| Abbott Laboratories | 3 | $202 |
| Corcept Therapeutics | 6 | $191 |
| Radius Health, Inc. | 9 | $182 |
| Madrigal Pharmaceuticals | 1 | $130 |
| Dexcom, Inc. | 1 | $105 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
Products named: iLet Bionic Pancreas, Omnipod, FREESTYLE LIBRE 3, Korlym, Tymlos, REZDIFFRA, Dexcom G6 Transmitter, RECORLEV.
Industry payments across LA — which companies pay providers there.
